Ganivian PFS 0.25 mg Injection 0.5 ml

Ganivian PFS 0.25 mg Injection 0.5 ml belongs to the group of medicines called antigonadotropin-releasing hormones used to treat infertility in women. It is indicated for the inhibition of premature luteinising hormone (LH) surges in women undergoing controlled ovarian hyperstimulation.

Ganivian PFS 0.25 mg Injection 0.5 ml contains Ganirelix, which works by inhibiting the action of gonadotropin-releasing hormone (GnRH), resulting in the suppression of the LH. It prevents women from ovulating too soon during the stimulation of their ovaries to produce a mature egg.

In some cases, Ganivian PFS 0.25 mg Injection 0.5 ml may cause side effects such as injection site reactions, nausea, and headache. Most of these side effects may not require medical attention and resolve gradually over time. However, you are advised to talk to the doctor if the side effects persist or worsen.

Let the doctor know if you are allergic to any components in Ganivian PFS 0.25 mg Injection 0.5 ml. Do not use Ganivian PFS 0.25 mg Injection 0.5 ml if you are pregnant or breastfeeding. There is no relevant use of Ganivian PFS 0.25 mg Injection 0.5 ml in children. Keep your doctor informed about your health condition and medicines to rule out any side effects.

Ganivian PFS 0.25 mg Injection 0.5 ml belongs to the group of medicines called antigonadotropin-releasing hormones used to treat infertility in women. It is indicated for the inhibition of premature luteinising hormone (LH) surges in women undergoing controlled ovarian hyperstimulation. Ganivian PFS 0.25 mg Injection 0.5 ml contains Ganirelix, which works by inhibiting the action of gonadotropin-releasing hormone (GnRH), resulting in the suppression of the LH. It prevents women from ovulating (release of the egg from the ovary) too soon during the stimulation of their ovaries to produce a mature egg.

• Nausea
• Headache
• Injection site reactions (redness, with or without swelling)

Do not use Ganivian PFS 0.25 mg Injection 0.5 ml if you are allergic to any of its components, if you are hypersensitive to gonadotropin-releasing hormone (GnRH) or a GnRH analogue, if you have a moderate or severe kidney or liver disease, or if you are pregnant or breastfeeding. During or following hormonal stimulation of the ovaries, ovarian hyperstimulation syndrome may develop. There may be a slightly increased risk of an ectopic pregnancy (pregnancy outside of the uterus) in women with damaged fallopian tubes. Inform the doctor if you weigh below 50 kg or above 90 kg. Let the doctor know if you are taking any other medicines, including vitamin/mineral supplements or herbal products.

Drug-Drug Interactions: No interactions found/established.

Drug-Food Interactions: No interactions found/established.

Drug-Disease Interactions: No interactions found/established.

• Include healthy fruits and vegetables in your diet.
• Avoid smoking and alcohol consumption.
• Try relaxation therapy. Read a book or listen to soothing music.
• Exercise moderately.
• Do yoga or meditation, as it helps relieve stress.

• You may need to have a negative pregnancy test before starting the treatment. 
• Tell your doctor immediately if you become pregnant during therapy.

Female infertility: It is a condition in which a woman cannot become pregnant even after trying for at least one year or six months if the woman is over 35 years old. Age, hormonal problems, physical problems, lifestyle or environmental factors could be the causes of infertility.